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Abstract
Background: There is an emerging theory suggesting that insulin, which is known to be the predominant
postprandial anabolic hormone, is also a major regulator of mitochondrial oxidative phosphorylation in
human skeletal muscle. However, little is known about its effects in the liver. Since there is a theoretical
relationship between glycogen metabolism and energy status, a simultaneous and continuous investigation
of hepatic ATP and glycogen content was performed in intact and isolated perfused liver by 31P and 13C
nuclear magnetic resonance (NMR) The hepatic rates of ATP and glycogen changes were evaluated with
different concentrations of insulin and glucose during continuous and short-term supply.
Results: Liver from rats fed ad libitum were perfused with Krebs-Henseleit Buffer (KHB)(controls) or
KHB containing 6 mM glucose, 30 mM glucose, insulin alone, insulin + 6 mM glucose, insulin + 30 mM
glucose. In the control, glycogenolysis occurred at a rate of -0.53 ± 0.021 %·min-1 and ATP content
decreased at a rate of -0.28 ± 0.029 %·min-1. In the absence of insulin, there was a close proportional
relationship between the glycogen flux and the glucose concentration, whereas ATP rates never varied.
With insulin + glucose, both glycogen and ATP rates were strongly related to the glucose concentration;
the magnitude of net glycogen flux was linearly correlated to the magnitude of net ATP flux: fluxglycogen =
72.543(fluxATP) + 172.08, R2 = 0.98.
Conclusion: Only the co-infusion of 30 mM glucose and insulin led to (i) a net glycogen synthesis, (ii) the
maintenance of the hepatic ATP content, and a strong positive correlation between their net fluxes. This
has never previously been reported. The specific effect of insulin on ATP change is likely related to a rapid
stimulation of the hepatic mitochondrial oxidative phosphorylation. We propose that variations in the
correlation between rates of ATP and glycogen changes could be a probe for insulin resistance due to the
action of substrates, drugs or pathologic situations. Consequently, any work evaluating insulin resistance
on isolated organs or in vivo should determine both ATP and glycogen fluxes.
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Background
In the metformin treatment of insulin resistance-related
complications, the mitochondrial effects of the drug are
probably crucial in explaining its unique efficacy [1].
Mitochondrial dysfunctions have been reported in the
muscle in type 2 diabetes [2] and in age-related insulin
resistance [3], suggesting a link between insulin action
and oxidative capacity in humans [4]. Thus, in healthy
humans, it has been demonstrated that high physiological
insulin sustained stimulated muscle protein synthesis and
mitochondrial ATP production rate for 8 hr [5]. However,
a rapid stimulatory action of insulin on ATP production
was not shown.
Owing to its strong capacity for glucose production and
utilization, the liver is a key regulator of glucose homeos-
tasis. One of its major functions is to store glucose as gly-
cogen after meals (glycogen synthesis) and to release
glucose from this glycogen (glycogenolysis) at the post-
absorptive state, which accounts for most endogenous
glucose production. Disturbance of this function is
thought to play a major role in the hyperglycemia of type
2 diabetes and in other insulin-resistant states. Despite
much work on the issue, the effect of insulin on hepatic
glycogenosynthesis remains controversial: insulin is
known to activate glycogen synthase in vitro [6], but
hepatic glycogenesis in vivo seems to need an increase in
both insulin and plasma glucose levels.
Glucose is the main energy substrate and its hepatic
metabolism can lead to ATP production during glycoge-
nolysis (by cytosolic glycolysis and mitochondrial oxida-
tive phosphorylation) or direct ATP consumption during
glycogen synthesis (or indirectly from gluconeogenesis).
Despite this strong link, no study to our knowledge has
simultaneously addressed the effects of insulin and glu-
cose on the rates of changes of hepatic glycogen and ATP
contents. This knowledge gap is particularly regrettable as
some studies have reported abnormal hepatic ATP con-
tents in insulin-resistant states as obesity [7] and nonalco-
holic steatohepatitis [8].
Nuclear magnetic resonance spectroscopy (NMR) is the
only technique that allows non-invasive repetitive and
simultaneous quantitation of both glycogen and ATP con-
tents in the isolated liver. Monitoring in real-time makes
it possible to calculate the rates of change in metabolites.
We chose to work on isolated whole liver, because it is not
subject to hormonal or nutritional parameters (in contrast
to in vivo models). Moreover, the isolated whole liver is a
closer model to physiological conditions than isolated
hepatocytes. The initial presence of hepatic glycogen is the
prerequisite for the kinetic study of its rate of change. As
the glycogen level is very low in the fasting state, this study
was performed on isolated livers from fed rats.
The purpose of this work was to explore in the liver the
relationship between the glycogen pathway and energy
metabolism and their dependence on insulin and/or glu-
cose supply.
Results
(1) Rates of change of liver glycogen content (Table 1)
Since glycogen has been shown to be nearly 100% NMR-
visible [9], changes in the peak area of the C1 resonance
of glycogen can be used to monitor and calculate the rate
of change in glycogen content in real time. In the absence
of glucose in the isotonic perfusion medium (KHB, con-
trol group A), a linear decrease in glycogen content
occurred without any lag time and its rate of disappear-
ance was -0.53 ± 0.021 %·min-1 (100% being considered
as the initial content = 73 ± 8.5 µmol glycosyl units·g-1
liver wet weight) (fig. 1).
Table 1: Rates of hepatic glycogen changes and ATP changes (nmol·min-1·g-1 of liver ww).
Experimental conditions
Control (KHB) 
Group A,
n = 7
G 6 mM 
Group B,
n = 8
G 30 mM 
Group C,
n = 8
Insulin 
Group D,
n = 5
Insulin + G 6 mM 
Group E,
n = 5
Insulin + G 30 mM 
Group F,
n = 5
GLYCOGEN -387 ± 73 (a) -64 ± 109* 
p = 0.02 vs control
(b) -474 ± 102 
NS vs control
(a) +52 ± 95** 
p = 0.003 vs control
(b) -277 ± 80 
NS vs control
-431 ± 29 
NS vs control
-29 ± 73 
p < 0.003 vs insulin NS vs 
G6(a)
+139 ± 47 
p < 0.00001 vs insulin
p = 0.015 vs G30(a)
ATP -7.28 ± 0.76 -10.14 ± 1.61 
NS vs control
-5.98 ± 1.22 
NS vs control
-8.06 ± 1.22 
NS vs control
-3.38 ± 0.17 
p = 0.03 vs insulin
p = 0.01 vs G6
-0.10 ± 0.42 
p = 0.003 vs insulin
p = 0.006 vs G30
100% glycogen = 73 ± 8.5 µmol glycosyl units·g-1 of liver ww; 100% ATP = 2.60 ± 0.65 µmol·g-1 of liver ww. The rates of glycogen changes were 
biphasic in group B and C; the first phase (a) lasted *20 min or **60 min. Mean ± SEM.Nutrition & Metabolism 2005, 2:32 http://www.nutritionandmetabolism.com/content/2/1/32
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In the presence of glucose in the KHB medium (Group B
and C), the glycogen content tended to remain near the
initial level for 20 min (6 mM glucose) and for 50 min
with 30 mM glucose. During this step, a slight decrease in
glycogen content with a rate of -0.087 ± 0.29 %·min-1 (p
= 0.022 vs. control) occurred in the 6 mM glucose group
and an increase in glycogen content was observed (+0.071
± 0.13%·min-1, n = 4, p = 0.002 vs. KHB perfusion) in the
30 mM glucose group (fig 2). This positive balance
between glycogenolysis and glycogenosynthesis was
about 52 nmoles glucosyl units·min-1·g-1. After this rela-
tively stable initial period, the apparent rate of glycoge-
nolysis was similar in all the groups (-0.65 ± 0.14 and -
0.38 ± 0.11%·min-1, in 6 mM and 30 mM glucose groups
respectively; NS vs. KHB perfusion).
With insulin alone in the KHB at different concentrations
(Group D) (60 mU/L, 120 mU/L or 600 mU/L), the
decrease in glycogen content was similar to that in the
KHB group. The results are expressed with different insu-
lin doses in the same group D for purposes of comparison
with the other liver groups (-0.59 ± 0.04%·min-1, n = 9)
(fig. 3)
In the presence of both 6 mM glucose and insulin (Group
E) the initial liver glycogen content was maintained for a
period ranging from 45 to 90 min (slight decrease in gly-
cogen content of -0.04 ± 0.38%·min-1, p = 0.01 vs. insulin
group (group D) and NS vs. 6 mM glucose alone (group
B). In the presence of both 30 mM glucose and insulin in
the medium (group F), we observed throughout perfusion
an increase in the rate of glycogen change in the isolated
liver (+0.19 ± 0.065%·min-1, p = 0.0001 vs. KHB per-
fusion; p < 0.0001 vs. insulin alone; NS vs. 30 mM glucose
alone) (fig. 3 and 4), leading to a glycogen content 2.6-
fold higher than in glucose 30 mM. This positive balance
was about 139 nmoles glycosyl units·min-1·g-1.
(2) Rates of Change of liver ATP content (Table 1)
In the absence of insulin, the liver ATP content in the con-
trol group (0 glucose) decreased at a rate of -0.28 ± 0.029
%·min-1, near -7.3 nmol. min-1·g-1, 100% ATP corre-
sponding to 2.60 ± 0.65 µmol/g liver wet weight (fig. 2
and 5). Similar rates were observed with 6 mM glucose
(group B; -0.39 ± 0.062) or with 30 mM glucose (group C;
-0.23 ± 0.047 %·min-1) (fig 2).
In the presence of insulin alone in the medium (group D),
there was also no significant difference compared to the
control group. At all insulin concentrations, no difference
was observed in ATP evolution so the results are pooled in
group D (-0.31 ± 0.047%·min-1, n = 9).
In the presence of both insulin and glucose (group E and
F), two different responses were observed: (i) with 6 mM
glucose (group E) a decrease in the ATP content (-0.13 ±
0.006 %·min-1) similar to that in the control group (ii)
with 30 mM glucose (group F) the rate of ATP decrease
was almost zero; -0.004 ± 0.016 %·min-1) (fig 3), so
100% of the initial content was maintained during the
first 90 min (fig. 6). This latter rate was significantly lower
than with 30 mM glucose alone (p = 0.031) or insulin
alone (p < 0.001).
Natural abundance 13C NMR spectra of two typical experi- ments at the beginning (A1 and B1) and after 115 min of per- fusion (A2 and B2) Figure 1
Natural abundance 13C NMR spectra of two typical 
experiments at the beginning (A1 and B1) and after 
115 min of perfusion (A2 and B2). A1 and A2 were 13C 
NMR spectra from a control rat perfused with Krebs-Hense-
leit buffer alone and B1 and B2 were 13C NMR spectra from 
rats perfused with both 30 mM glucose and insulin. Major 
resonances are assigned to (a,g) fatty acid, (b) C-1 glycogen, 
(c) glucose and glycogen (C-3β, C-5β glucose, glycogen; C-2 
glucose, C-3α glucose; C2, C-5α glucose, C-5 glycogen; C-
4αβ glucose, glycogen), (d) C-6 glucose, glycogen, (e) 
choline, (f) ethanolamine. Note the C-1 glycogen (b) 
decrease in the KHB group (A1 and A2) and the relative sta-
bility of the glycogen content of the liver during perfusion of 
both 30 mM glucose and insulin (B1 and B2).Nutrition & Metabolism 2005, 2:32 http://www.nutritionandmetabolism.com/content/2/1/32
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(3) Relationship between rates of hepatic glycogen and 
ATP changes
Simultaneous analysis of ATP and glycogen contents
under the same experimental conditions showed differ-
ences in the evolution of the net metabolic flux that was
closely dependent on the presence or absence of insulin.
In the absence of insulin, there was a close proportional
relationship between the glycogen flux and the concentra-
tion of glucose supply, whereas the ATP rates were inde-
pendent of the glucose concentration (fig 2). Conversely,
in the presence of both glucose and insulin, glycogen and
ATP rates were both strongly related to the perfusate glu-
cose concentration (fig 3). The magnitude of net glycogen
flux was thus correlated with the net ATP flux : fluxglycogen
= 72.543(fluxATP) + 172.08, R2 = 0.98 (fig 7), and the final
glycogen content was significantly higher than in the pres-
ence of glucose alone.
Discussion
Recent evidence supports the hypothesis that insulin, the
key postprandial hormone involved in fuel metabolism,
is also a major regulator of mitochondrial oxidative phos-
phorylation in human skeletal muscle [4,5]. However, lit-
tle is known about its effects in the liver.
Given the theoretical relationship between glycogen
metabolism and energy status, hepatic ATP and glycogen
content were investigated in rat liver. Since methods based
on extraction of glycogen and/or ATP from liver cannot
monitor their evolution in real time in the same intact
liver, NMR spectroscopy was used to study the appearance
or disappearance of metabolites in the same organ. This
work is the first to investigate in real time the rapid effects
of glucose and/or insulin on the rates of changes in glyco-
gen and ATP content in the isolated liver of fed rats.
Insulin alone had no effect on the natural decrease in
hepatic glycogen and ATP contents during the 2-hr per-
fusion. The increase in the concentration from 0 to 30 mM
of glucose alone in the perfusate maintained liver glyco-
gen in a dose-dependent manner. Moreover, glucose had
a glycogen-sparing effect, in agreement with other data
[10,11], but had no effect on basal ATP consumption, par-
ticularly at 30 mM. Indeed it is known that the glucose
concentration must be around 20–30 mM to induce both
a decrease in the activity of phosphorylase a below 10%
(of total activity) and a subsequent activation of the glyco-
gen synthase [6,12].
Only co-perfusion with insulin and 30 mM glucose led to
a glycogen synthesis 2.6-fold (260%) higher than with 30
mM glucose alone, and this positive balance was in agree-
ment with previous results obtained in fasted rats in con-
ditions of neoglucogenesis (addition of alanine and/or
lactate) [9] or with fructose [11]. This isolated liver model
clearly demonstrates that insulin acts directly on the cells,
thereby invalidating the hypothesis of an insensitivity of
the liver to insulin developed elsewhere [13]. Since glyco-
gen synthesis implies some UTP (and ATP) use, one might
expect an increase in ATP consumption resulting in a
reduction of liver ATP content. In fact, the presence of
both 30 mM glucose and insulin led to (i) the mainte-
nance of the hepatic ATP content, demonstrating that ATP
consumption equaled ATP synthesis, and (ii) a net glyco-
gen synthesis reflecting a positive balance between glycog-
enolysis and glycogen synthesis. More significant is the
evidence of a strong linear correlation between the net
fluxes of these two metabolites. We did not differentiate
between the reduction of glycogenolysis and the enhance-
ment of glycogenosis, or between the separate rates of ATP
production and utilization that led to modifying hepatic
glycogen and ATP contents. However, our global kinetic
study of the balance between the synthesis and lysis path-
ways clearly underlines for the first time that it is only in
the presence of insulin that the net flux of ATP correlates
with the net flux of hepatic glycogen synthesis from exog-
enous glucose in the isolated liver.
To date, the role of insulin in the correlation of the net
hepatic flux of ATP and glycogen has not been described,
although previous reports point to a link between carbo-
hydrate metabolism and ATP pathways. Insulin and glu-
Rates of liver glycogen and ATP changes in absence of insulin  in the perfusate Figure 2
Rates of liver glycogen and ATP changes in absence 
of insulin in the perfusate. The results are expressed in 
%·min-1 (mean ± SEM; 100% initial glycogen content = 73 ± 
8.5 µmol glycosyl units·g-1 liver wet weight; 100% initial ATP 
content = 2.60 ± 0.65 µmol/g liver wet weight). Only the rate 
of glycogen content increased with the perfusate glucose 
concentration.Nutrition & Metabolism 2005, 2:32 http://www.nutritionandmetabolism.com/content/2/1/32
Page 5 of 9
(page number not for citation purposes)
cose perfusions during resuscitation of rats from
hemorrhagic shock increase the hepatic ATP content [14].
Both liver glycogen and ATP contents are decreased by
fasting and exercise [15]. Cortez-Pinto et al [8] reported
that recovery from hepatic ATP depletion was reduced
with a body mass increase in healthy humans and was
severely impaired in subjects with nonalcoholic steato-
hepatitis, a condition associated with hepatic insulin
resistance. This result is corroborated by an inverse corre-
lation observed between hepatic ATP content and Body
Mass Index [7].
In 48 hr-cultured hepatocytes in the presence of insulin, a
previous study showed an increase in the ATP concentra-
tion from 12 hr with a concomitant close correlation
between the increases in exogenous glucose transport rate
and glycogen content [16]. However, the authors under-
lined that no clear effect of insulin on glucose transport
was found in the isolated 2 hr-perfused liver system.
Moreover, the main role of insulin in maintaining the
metabolic competence of cultured hepatocytes could be
linked to the absolute ATP concentration rather than to
the energy charge [17]. In rat hepatocytes and muscle,
insulin, which otherwise has no significant effect on respi-
ration, acts specifically on the mitochondrial Krebs cycle,
within 30 sec, to stimulate by 30% the oxidation of only
carbons 2 and 3 of pyruvate (or acetate) to CO2 [18].
Other authors [19] showed in the isolated hepatic mito-
chondria of rats treated with insulin for 9 weeks that the
hormone improved the function of oxidative phosphor-
ylation by increasing (i) ATP synthase activity, (ii) the
ADP/O ratio and (iii) the respiratory control ratio. It may
therefore be hypothesized that the rapid action of insulin
(in the presence of exogenous glucose) on liver glycogen
flux is exerted through the increase in ATP turnover, via (i)
an enhancement in glycolytic ATP production and/or (ii)
an increase in ATP flux originating from oxidative phos-
phorylation related to the activation of Krebs cycle and/or
(iii) an increase in the oxidative phosphorylation yield.
Conclusion
Beside extending numerous NMR studies using non-phys-
iological conditions (such as clamps to maintain insulin
and glucose levels; review in [20]) or expensive 13C-labe-
ling [21], this kinetic study performed by natural abun-
dance NMR in isolated liver describes a simple reliable
method to analyze the link between ATP and glycogen.
The main finding was a close metabolic link between
hepatic ATP and glycogen induced by insulin in the pres-
ence of glucose. Such a major role for energy metabolism
is in agreement with the emergent hypothesis suggesting a
defect in mitochondrial oxidative phosphorylation in
insulin-resistance [22]. We propose that variations in the
correlation between rates of ATP and glycogen changes
could be a probe for insulin resistance action of sub-
strates, drugs or pathologic situations. Using NMR surface
coil techniques, it should be possible to address this ques-
tion in a similar fashion in vivo in the rat and in clinical
investigations in human. Any work evaluating insulin
Time course of the change in hepatic glycogen content  throughout the entire protocol perfusion in presence of insu- lin Figure 4
Time course of the change in hepatic glycogen con-
tent throughout the entire protocol perfusion in 
presence of insulin. The results are presented for three 
typical individual experiments: insulin alone (group D), insulin 
+ 6 mM glucose (group E) and insulin + 30 mM glucose 
(group F). The results are expressed as the percentage of ini-
tial glycogen content, 100% being the value at the onset of 
the experiment. Note that the decrease in glycogen content 
observed with insulin alone was similar to that in the KHB 
control group.
Rates of liver glycogen and ATP changes in presence of insu- lin in the perfusate Figure 3
Rates of liver glycogen and ATP changes in presence 
of insulin in the perfusate. The results are expressed in 
%·min-1 (mean ± SEM; 100% initial glycogen content = 73 ± 
8.5 µmol glycosyl units·g-1 liver wet weight; 100% initial ATP 
content = 2.60 ± 0.65 µmol/g liver wet weight). The rates of 
both ATP and glycogen contents increased with the per-
fusate glucose concentration.Nutrition & Metabolism 2005, 2:32 http://www.nutritionandmetabolism.com/content/2/1/32
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resistance on isolated organs or in vivo should determine
both ATP and glycogen fluxes.
Methods
Animal perfusion conditions
Male Wistar rats weighing between 80 and 120 g were
used. Rats were obtained from the existing colony in the
animal unit of Bordeaux 2 University. They were main-
tained on standard rat chow and were housed in an envi-
ronmentally controlled room (temperature, humidity and
airflow conditions) with a 12-hour light/dark cycle. The
standard non-purified diet contained by weight (g/100 g):
63 starch (corn, sorghum, wheat, oats, barley), 22 protein,
3.5 fat, 6 fiber, 1 vitamin mixture and 4 salt mixture (Ral-
ston, Purina, St. Louis, MO). The rats were fed ad libitum
to facilitate glycogen synthesis and visualization of glyco-
gen liver store at the beginning of the experiment. The rats
were anesthetized with intraperitoneal barbiturate injec-
tion (pentobarbital sodium: 50 mg/kg of body weight).
The rat liver was commonly used to investigate energetic
metabolism [23] and glycogen turn-over [9]. The liver (4–
6 g) from rats was perfused in situ through the portal vein
(anterograde perfusion technique) as previously
described [23]. The bile duct was cannulated in order to
avoid mixing of bile with the surrounding medium. The
perfusion was performed at 37°C with 95% O2–5% CO2
gassed Krebs-Henseleit buffer (KHB) as a flow rate (5 ml/
min·g wet weight (ww)). The KHB composition was
(mmol/L): 120 NaCl, 4.70 KCl, 1.20 MgSO4, 25 NaHCO3,
1.20 K2HPO4-KH2PO4, 1.30 CaCl2, 0.3 mM Na-pyruvate
and 2.10 mM Na-lactate (pH = 7.35 at 37°C). The temper-
ature of the perfusion circuit was regulated with a thermo-
static bath. The liver (perfused in a non-recirculating
mode) was then excised from the rat abdomen and trans-
ferred to a 20-mm diameter NMR cell. The perfusate tem-
perature and pH were monitored before entering and after
leaving the liver by continuous flow pH electrodes and
temperature probes. High-grade chemicals were pur-
chased from Sigma Chemicals (Saint Louis MO) except
where otherwise specified.
This study complied with NIH guidelines (national
research 1985).
Time course of the change in hepatic ATP content through- out the entire protocol perfusion in presence of insulin Figure 6
Time course of the change in hepatic ATP content 
throughout the entire protocol perfusion in presence 
of insulin. The results are presented for three typical indi-
vidual experiments: insulin alone (group D), insulin + 6 mM 
glucose (group E) and insulin + 30 mM glucose (group F). The 
results are expressed as the percentage of initial ATP con-
tent, 100% being the value at the onset of the experiment. 
Note that in the control KHB group, the 6 mM glucose 
group and the 30 mM glucose group, the ATP content 
decreased at a similar rate to the insulin group.
31P NMR spectra of 2 typical experiments at the beginning  (A1 and B1) and after 115 min of perfusion (A2 and B2) Figure 5
31P NMR spectra of 2 typical experiments at the 
beginning (A1 and B1) and after 115 min of perfusion 
(A2 and B2). A1 and A2 were 31P NMR spectra from a con-
trol rat perfused with Krebs-Henseleit buffer alone and B1 
and B2 were 31P NMR spectra from rat perfused with both 
30 mM glucose and insulin. Major resonances are assigned to 
(a) phosphomonoesters, (b) phosphocholine, (c) intracellular 
inorganic phosphate, (d) glycerol-3-phosphorylcholine, (f) 
nucleoside-5'-triphosphates (γNTP) and diphosphates 
(βNDP), (g) α-NTP and α-NDP, (h,i) nicotinamide adenine 
dinucleotide and uridine-5'-diphosphoglucose, (j) βNTP. The 
external reference is not shown (18.40 ppm). Note the 
βATP (j) decrease in the KHB group (A1 and A2) and the rel-
ative stability of the ATP content of the liver during the per-
fusion of both 30 mM glucose and insulin (B1 and B2).Nutrition & Metabolism 2005, 2:32 http://www.nutritionandmetabolism.com/content/2/1/32
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Experimental procedures
Different groups of liver were perfused for 150 min under
various medium concentrations of glucose and insulin
(Actrapid, Novo Nordisk A/S 2880 Bagsvaerd Danemark).
Insulin and glucose concentrations in this work reflect the
portal concentration in in vivo conditions [24-26]. 60
mU/L of insulin is known to be the physiological level in
the portal vein in the fasting state but this concentration
probably increases in the fed state [24]. To study the effect
of insulin on the liver, we chose to use (i) the physiologi-
cal concentration, and (ii) 2- and 10-fold this concentra-
tion to mimic the fed portal state. Plasma glucose
concentration in rats is around 6 mmol/L but the level in
the portal vein during the fed state is higher (around 30
mmol/L) [25,26].
- Group A: control group (KHB alone) (n = 7)
- Group B: D-glucose 6 mM (n = 8)
- Group C: D-glucose 30 mM (n = 8)
- Group D: Insulin 60 mU/L (n = 2)
Insulin 120 mU/L (n = 3)
Insulin 600 mU/L (n = 4)
- Group E: D-glucose 6 mM + insulin 60 mU/L (n = 5)
- Group F: D-glucose 30 mM + insulin 60 mU/L (n = 5)
In the absence of a dose effect of insulin in group D, we
performed the last experiments (insulin + glucose i.e. E
and F groups) with 60 mU/L insulin concentration. More-
over, in some experiments performed with glucose 30
mM, no difference was observed when insulin concentra-
tion was 120 mU/L instead of 60 mU/L (data not shown).
Perfusion lines were saturated by KHB containing insulin
at least 30 min before the beginning of perfusion to avoid
absorption phenomena during the experiment as
reported by others [25].
Correlation between the rates of ATP and glycogen changes in presence of insulin according to the perfusate glucose concen- tration Figure 7
Correlation between the rates of ATP and glycogen changes in presence of insulin according to the perfusate 
glucose concentration. The rates are expressed in nmol·min-1·g-1. The equation for the linear correlation is fluxglycogen = 
72.543(fluxATP) + 172.08, R2 = 0.98. To obtain a positive net flux of glycogen (net synthesis), the net ATP consumption must 
not exceed 2.4 nmol·min-1·g-1.Nutrition & Metabolism 2005, 2:32 http://www.nutritionandmetabolism.com/content/2/1/32
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NMR methodology
The spectra were obtained using a 31P/13C double tuned
20 mm probe operating at 9.4T. Liver ATP content was fol-
lowed by 31P NMR and carbohydrate content in natural
abundance was assessed by 13C NMR. It was therefore pos-
sible to calculate the rate of changes of glycogen and ATP
content. 31P and 13C NMR spectra were recorded at 161.9
and 100.6 MHz respectively on a DPX400 spectrometer.
The magnetic field was adjusted on the water proton sig-
nal. 31P NMR spectra were obtained every 2 minutes (240
free induction decays (FID)) without proton decoupling.
Radiofrequency pulses (70° flip angle) and 10,000 Hz
spectral width were used for data acquisition. 13C NMR
spectra were proton-decoupled using a gated bilevel
mode.  13C NMR spectra were obtained every 8 min
(500FID) resulting from a 66° radiofrequency pulse
repeated every second (25,000 Hz spectral width).
Lorentzian line broadening of 15 Hz was applied before
Fourier transformation for both 31P and 13C NMR spectra.
Chemical shift of phosphorylated metabolites was
expressed relative to the position of resonance in the fre-
quency scale of an internal reference set (glycerophospho-
ryl-choline) at 0.47 ppm.13C chemical shifts were
expressed from an external silicone reference (1.45 ppm).
During the initial perfusion period, any liver showing an
increase in the intensity of inorganic phosphate resonance
occurring with a concomitant decrease in NTP signals
probably reflecting some partial lobe ischemia was dis-
carded.
Analysis
ATP and glycogen levels were estimated from peak areas
and expressed as a percentage of the initial value. Relative
changes in ATP levels, reflecting the dynamic changes in
ATP liver content, were estimated from changes in the area
of the spectral peaks of the β-phosphate of nucleoside tri-
phosphates.  βATP represents at least 80% of the NTP
(around -18 ppm) [27]. The glycogen signal was charac-
terized by a narrow signal at 100.5 ppm (C-1 resonance of
glycosyl subunit in glycogen). The difference between the
observed change in C1 resonance glycogen represents an
estimate for the amount of glycogen that was broken
down or synthesized during the time interval. 13C NMR
quantification of glycogen content at the beginning of
KHB perfusion was performed from a calibration curve
established with oyster glycogen (0 to 185 mM glycosyl
units).
Rate was expressed as %·min-1 or nmol. min-1·g-1 and can
be calculated from the change in the metabolite signal
area, as the linewidth remained constant throughout the
experiment:
Rate = 0 : Synthesis = lysis
Rate>0 : Synthesis>lysis
Rate<0 : Synthesis<lysis
Data in the text, table and figures are given as mean ±
SEM. Statistical analysis was performed with the software
package Excel. A t test was used after a one-way ANOVA to
identify significant differences between different perfusate
compositions. Probability values of P < 0.05 were consid-
ered to be significant.
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